The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients
- PMID: 34276649
- PMCID: PMC8281350
- DOI: 10.3389/fimmu.2021.654652
The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients
Abstract
Objectives: This study aimed to determine the prevalence and localization of complement factor C4d in renal biopsies from patients with lupus nephritis (LN), as well as its associations with the disease's clinico-pathological features. The correlation between arteriolar C4d deposition and renal microvascular lesions (RVLs) was further analyzed.
Methods: A total of 325 biopsy-proven LN patients were enrolled, and their clinico-pathological data were collected. C4d staining of renal biopsies was performed by immunohistochemistry. The associations between C4d deposition and the clinico-pathological features were further analyzed.
Results: C4d deposition was present in most (98.8%) renal specimens in our cohort. These deposits were localized in the glomeruli (98.2%), tubular basement membrane (TBM) (43.7%), arterioles (31.4%), and peritubular capillary (33.8%). Patients with TBM C4d staining had higher disease activity (measured with the Systemic Lupus Erythematous Disease Activity Index) and higher National Institutes of Health pathological activity and chronicity indices (all P < 0.01). Patients with arteriolar C4d deposition were more likely to develop RVLs (91.2%) compared to those with no arteriolar C4d deposition (78.0%; P = 0.004), especially with two or more types of RVLs (P < 0.001). During the mean follow-up of 55.8 months, arteriolar C4d was related to worse renal outcomes [hazard ration (HR): 2.074, 95% confidence interval (CI) 1.056-4.075, P = 0.034]. Multivariate Cox hazard analysis showed that co-deposition of arteriolar C4d and C3c was an independent risk factor (HR: 3.681, 95% CI 1.519-8.921, P = 0.004) for predicting renal outcomes.
Conclusions: C4d deposition was common in renal tissues from LN patients. TBM C4d deposition was related to the disease activity, and arteriolar C4d deposition was associated with RVLs and worse renal outcomes.
Keywords: C4d; complement; lupus nephritis; prognosis; renal microvascular lesions.
Copyright © 2021 Ding, Yu, Wu, Tan, Qu and Yu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.Int J Clin Exp Pathol. 2013 Sep 15;6(10):2157-67. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24133594 Free PMC article.
-
Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.Arthritis Rheum. 2008 Aug;58(8):2460-9. doi: 10.1002/art.23662. Arthritis Rheum. 2008. PMID: 18668574
-
Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.Lupus. 2012 Jan;21(1):13-26. doi: 10.1177/0961203311422093. Epub 2011 Sep 29. Lupus. 2012. PMID: 21959138
-
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis.Lupus. 2024 Feb;33(2):111-120. doi: 10.1177/09612033231226351. Epub 2024 Jan 16. Lupus. 2024. PMID: 38227433 Review.
-
Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.Clin Transplant. 2007 Mar-Apr;21(2):159-65. doi: 10.1111/j.1399-0012.2007.00487.x. Clin Transplant. 2007. PMID: 17425739 Review.
Cited by
-
Lupus Nephritis Biomarkers: A Critical Review.Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805. Int J Mol Sci. 2024. PMID: 38255879 Free PMC article. Review.
-
The role of complement in kidney disease.Nat Rev Nephrol. 2023 Dec;19(12):771-787. doi: 10.1038/s41581-023-00766-1. Epub 2023 Sep 21. Nat Rev Nephrol. 2023. PMID: 37735215 Review.
-
Renal C4d is a potential biomarker of disease activity and severity in pediatric lupus nephritis patients.Front Pediatr. 2023 Jun 1;11:1193917. doi: 10.3389/fped.2023.1193917. eCollection 2023. Front Pediatr. 2023. PMID: 37325343 Free PMC article.
-
Complement as a Biomarker for Systemic Lupus Erythematosus.Biomolecules. 2023 Feb 15;13(2):367. doi: 10.3390/biom13020367. Biomolecules. 2023. PMID: 36830735 Free PMC article. Review.
-
Thrombotic microangiopathy mediates poor prognosis among lupus nephritis via complement lectin and alternative pathway activation.Front Immunol. 2022 Dec 13;13:1081942. doi: 10.3389/fimmu.2022.1081942. eCollection 2022. Front Immunol. 2022. PMID: 36582241 Free PMC article.
References
-
- Appel G, D’Agati R. Secondary Glomerular Disease. In: Brenner BM, editor. Brenner & Rector’s The Kidney, 8th edn. Philadephia: WBSaunders; (2008). p. 1067–146.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
